Sign in to follow
Search Results

0 results for 'Grant Eisenhofer'

You can use to get even better search results
August 28, 2009 |

Big Surprise: Plaintiffs Firms Back SEC's Shareholder Rights Plan

A rare joint letter to the U.S. Securities and Exchange Commission from a group of defense law firms over shareholder proxy access is receiving an even rarer response from nine of the country's largest plaintiffs law firms. The firms, more typically seen in shareholder litigation than in regulatory squabbles, include Labaton Sucharow; Bernstein Litowitz Berger & Grossman; and Cohen Milstein Sellers & Toll. The letter, dated Tuesday, supports the SEC's proposal to allow shareholders to nominate directors, exactly what the defense firms argued against last week.
3 minute read
August 27, 2009 |

Plaintiffs Firms Show Support for SEC Shareholder Rights Proposal

A rare joint letter to the SEC from a group of defense law firms over shareholder proxy access is receiving an even rarer response from nine of the country's largest plaintiffs law firms. The letter supports the SEC's proposal to allow shareholders to nominate directors, exactly what the defense firms argued against last week. If approved, public companies would be required to include in their proxy materials shareholder nominees for directors that could comprise up to a quarter of the board.
3 minute read
At the Last(er) Minute, Delaware Vice-Chancellor Blasts Barclays, Halts $5.3 Billion Del Monte Buyout
Publication Date: 2011-02-14
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Barclays stood to earn double fees as the financial adviser to Del Monte and the source of financing for the private equity consortium that planned to buy the company. But there were a few things that the bank neglected to tell Del Monte's board along the way--and Vice-Chancellor Laster had a problem with that.

November 26, 2003 |

Judge Refuses to Dismiss Analyst Fraud Claims in WorldCom Litigation

Press reports about widespread conflicts among Wall Street stock analysts were not enough to put investors on notice about the allegedly "illicit relationship" between WorldCom, Salomon Smith Barney and its star telecommunications analyst Jack Grubman, a federal judge ruled Tuesday, rejecting motions to dismiss claims brought on behalf of an Ohio pension fund. The ruling was the latest by Judge Denise Cote in the largest securities fraud case in the nation's history.
4 minute read
Plaintiffs Get Sympathy But No Injunction in Shareholder Litigation over $21 Billion El Paso Deal
Publication Date: 2012-03-01
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The plaintiffs lawyers leading El Paso shareholders' assault on the company's planned $21 billion acquisition by Kinder Morgan lost their bid to enjoin the sale late Wednesday, but they sure got the judge's attention. Can they translate the opprobrium of Delaware Chancery Court chancellor Leo Strine Jr. into a big payday--and more than a little embarrassment for El Paso advisor Goldman Sachs?

November 14, 2007 |

Vioxx Settlement Buoys Lawyers in Economic-Damage Suits vs. Merck

The $4.85 billion Vioxx settlement announced last week is bolstering hopes of another set of plaintiffs: investors and employees who filed securities, derivative and ERISA suits against the company.
6 minute read
Did D&O Insurer Balk at Funding Riggio Settlement in B&N Case?
Publication Date: 2012-06-14
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

In an unusual move, Barnes & Noble founder Leonard Riggio paid for a $29 million shareholder settlement out of his own funds. Why? His directors and officers policy likely has a "personal profit" exclusion, which denies coverage when the insured loses money he wasn't legally entitled to.

November 15, 2007 |

Vioxx Settlement Buoys Lawyers in Shareholder, ERISA Suits Against Merck

The $4.85 billion Vioxx settlement announced last week is bolstering hopes of another set of plaintiffs: investors and employees who filed securities, derivative and ERISA suits against the company. Plaintiffs in 10 cases, consolidated in New Jersey's federal district court, claim they were financially harmed by Merck's marketing of a dangerous drug, and their attorneys say the product liability settlement shows the damages were high. Several of the cases, though, have some obstacles to overcome.
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now